Clinical Trial Update: The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151' [Phase 1]

View source ↗

Summary

Phase 1 study updating safety and pharmacokinetics data comparing single-dose administration of AD-115A and AD-1151 in gastric ulcer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• AD-1151
• AD-115A

Snippet

Sponsor: Addpharma Inc. | Conditions: Gastric Ulcer | Phase 1 | Status: COMPLETED